GlassScriptPhysician profile
Thomas L Lazoff
NPI 1457354433
$2,770.17
in general payments reported to CMS, 2019-2025
27 companies · $133 in 2025
The $133 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $316 · 2020: $1,380 · 2021: $353 · 2022: $240 · 2023: $276 · 2024: $74.07 · 2025: $133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $482.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $482.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,012.29 | 2020-2021 | |
| Stimwave Technologies Incorporated | $378.54 | 2020 | |
| Abbvie INC. | $255.11 | 2022-2025 | |
| Tersera Therapeutics LLC | $172.70 | 2019-2022 | |
| Allergan, INC. | $120.09 | 2019-2021 | |
| Collegium Pharmaceutical, INC. | $106.06 | 2019-2023 | Xtampza |
| Electronic Waveform Lab, INC. | $98.90 | 2023 | |
| Pfizer INC. | $79.77 | 2019-2021 | |
| Medtronic, INC. | $78.48 | 2021-2024 | Intellis Adaptivestim |
| Fidia Pharma USA INC. | $74.57 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $35.83 | 2025 | Iovera |
| Zyla Life Sciences, INC. | $32.65 | 2019 | |
| Merz Pharmaceuticals, LLC | $31.50 | 2022 | |
| Scilex Pharmaceuticals INC. | $31.43 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $30.58 | 2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Painteq LLC | $29.38 | 2023 | Painteq |
| Medtronic USA, INC. | $26.76 | 2020 | |
| Stryker Corporation | $25.04 | 2025 | Mild Device Kit |
| Redhill Biopharma INC. | $23.04 | 2021 | |
| Grt US Holding, INC. | $22.30 | 2022 | |
| Depuy Synthes Sales INC. | $19.20 | 2022 | |
| Ibsa Pharma INC. | $18.07 | 2022 | |
| Vertos Medical, INC. | $15.10 | 2023 | Mild Device Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.68 | 2021 | |
| Avanos Medical | $13.68 | 2025 | Generator |
| Si-Bone, INC. | $13.03 | 2022 | |
| Lilly USA, LLC | $11.39 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Lazoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.